T he usefulness of the resting post-myocardial infarction electrocardiogram (ECG) as a tool for assessing subsequent risk in patients with myocardial infarction (MI) is uncertain. The risk of death or complications is higher in those with generalized abnormalities' and, specifically, in individuals with Q or QS wave abnormalities, left ventricular hypertrophy, ST segment elevation or depression, and conduction block disturbances.2-8 Data from population-based studies with long-term follow-up are lacking, however. Furthermore, few studies have examined the relation between the persistence or regression of electrocardiographic abnormalities and prognosis after MI.
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The purpose of this investigation was to study the association of electrocardiographic abnormalities after MI with the long-term risk of reinfarction and coronary death. Whether specific electrocardiographic abnormalities such as ST segment and T wave changes, left ventricular hypertrophy, and conduction block disturbances present 1 year after MI can modify the long-term prognostic outlook in those persons with or without persistent Q wave evidence of MI was evaluated. The Framingham Heart Study offered a unique opportunity to examine these issues in a population-based cohort of survivors of MI with biennial ECGs and follow-up of up to 32 years.
Methods
The general methodology of the Framingham Study has been previously described.9 In short, it involved the follow-up of 5,209 men and women, initially (in 1948) aged 30-62 years, for the evaluation of risk factors for coronary heart disease. Biennial examinations included a detailed physical examination, chest x-ray, 12-lead resting ECG, and a complete panel of blood tests.9
Study Population
During the first 30 years of follow-up (through the 16th biennial examination), a total of 388 patients with an initial Q wave MI were identified, with each event assigned the date of hospitalization or diagnosis by a physician. These clinically recognized infarctions required symptoms that promoted medical evaluation followed by a diagnosis based on characteristic electrocardiographic changes (loss of initial QRS potentials indicated by the development of Q waves of at least 0.04 seconds).3 Q wave infarctions that were clinically unrecognized (n=225) and incidentally detected by routine ECGs were not included in this investigation because of the uncertainty of their dating. Additionally, MIs prevalent at the initial Framingham examination (n=49) and diagnosed by autopsy evidence only (n=34), or clinically recognized but without a diagnostic Q wave pattern ECG (n=84) were not eligible for inclusion in this study. Of the 388 initial recognized Q wave MIs, 97 did not survive to attend a follow-up exam, leaving 291 eligible for baseline examination of risk factors. An additional 40 (14%) survived but did not attend the required follow-up exam for inclusion. Of the 97 who did not survive, 88 died of coronary heart disease (including three who died suddenly within 1 hour), and nine died of noncoronary causes. This left 251 (190 men and 61 women) subjects who returned for a follow-up examination, on average, 1 year after their initial MI, at which time a resting 12-lead ECG and risk factor measurements were obtained (Table 1) . Those Definition of End Points and Follow-up All subjects were followed for the occurrence of recurrent MI (fatal or nonfatal) or death from coronary heart disease through the 17th biennial examination, which included up to 32 years (mean, 10.1 years) of follow-up. Reinfarctions were used as acceptable end points regardless of whether they were clinically recognized; those that were unrecognized were assigned the midpoint of the date between the examination first demonstrating electrocardiographic evidence of the new MI and the date of the last attended examination where it was not present. Deaths from coronary heart disease included only those deaths from coronary arteriosclerosis, thus excluding about 10% of cardiovascular deaths from other causes (e.g., aortic aneurysm and congenital heart disease). Follow-up time was defined as the number of days from the assigned date of the initial MI to the date of reinfarction or death from coronary heart disease.
Data Analysis
The 1) . X-ray left ventricular hypertrophy required that the heart chamber be enlarged by extension of the left apex of the heart towards the left, with an elevation and squaring of the apex, whereas generalized cardiac enlargement indicated a rounding and expanding of the heart to both the right and left. 3 Where electrocardiographic classification was used to predict reinfarction, an additional 65 subjects were excluded. This included 1) 10 subjects who experienced reinfarction before attending the post-MI baseline examination for measurement of risk factors, and 2) 55 subjects who died of coronary heart disease but not identified as having a documented recurrent MI. A total of 186 subjects with a follow-up ECG were, therefore, eligible for analysis with reinfarction as an end point. Multivariable analyses were based on the number of cases with complete riskfactor data available.
The association of each of four specific electrocardiographic abnormalities present in the ECG before MI, that is, 1) ST segment abnormality, 2) T wave abnormality, 3) left ventricular hypertrophy, and 4) atrioventricular block (first degree or higher) with the long-term risk of coronary death adjusted for age and sex, was evaluated by Cox proportional hazards regression. Because of the small number of subjects with bundle branch block prior to MI, this was not evaluated in this portion of the analyses. Each of these features, one or more of which were present in approximately 80% of those persons with an abnormal overall electrocardiographic impression were also examined together by similar techniques in multivariable analyses with post-MI electrocardiographic classification. This allowed for examining whether the prognostic value of the post-MI ECG could be explained by preexisting electrocardiographic abnormalities.
Analysis of variance was used to compare riskfactor differences (for serum cholesterol, systolic blood pressure, and relative weight) among categories of post-MI electrocardiographic status, and the Student's t test was used to evaluate such differences according to the presence or absence of specified electrocardiographic abnormalities (i.e., nonspecific ST segment and T wave abnormalities, left ventricular hypertrophy, and atrioventricular block). The x2 test of proportions was used for these analyses for diabetes, which was a binary variable.
From the regression coefficients obtained, relative risks (RRs) and 95% confidence limits were calculated to compare the risk of long-term reinfarction or coronary mortality in each abnormal electrocardiographic classification group as compared with the reference group consisting of those with no definite abnormalities. RRs relating the presence versus the absence of specific electrocardiographic abnormalities with these end points were calculated; ap value of 0.05 or less was considered statistically significant.
Results
Of the 251 subjects in whom a follow-up ECG was obtained, 101 subsequently died of coronary disease and 70 were diagnosed with a recurrent infarction. One third of coronary deaths occurred within 5 years of initial infarction, and 62% occurred within 10 years. Persistence of pathological Q waves was evident in 183 (73.0%) subjects, a definite electrocardiographic abnormality without Q wave MI was present in 37 (14.7%), and 31 (12.4%) showed a normalized ECG. The presence of ST segment or T wave abnormalities, left ventricular hypertrophy, atrioventricular block, bundle branch block or any of these in combination accompanied 75 of those with a persistent Q wave MI. Electrocardiographic classification on follow-up examination was significantly different between men and women, with women more likely to have residual abnormalities other than a diagnostic Q wave pattern (p<0.05) ( Table 2) . Furthermore, electrocardiographic recovery patterns were significantly different by location of initial infarction, with twofold the proportion of those with an inferior MI as compared with those with an anterior MI demonstrating a follow-up ECG with no definite abnormality (17% vs. 8%, respectively). Compared with the proportion of those with no (Table 8) .
The 1) prevalences of preexisting electrocardiographic abnormalities on the ECG before MI and 2) associations of these abnormalities with the risk of coronary death post-MI are presented in Table 9 . The various ECG abnormalities are not exclusive classifications; more than one abnormality can be present in a given individual. Although 236 subjects had an ECG before MI, not all subjects had information on specific electrocardiographic abnormalities available. Approximately one fourth (25.8%) of subjects who subsequently had an infarction had an abnormal ECG before MI, with nonspecific ST segment and T wave abnormalities being the most prevalent of the specified abnormalities. In Table 9 , the association of post-MI electrocardiographic status adjusted for the effect of preexisting electrocardiographic abnormalities is also presented. The electrocardiographic abnormalities before MI that are significantly associated with coronary death include nonspecific ST segment changes (RR=4.67,p<0.001), nonspecific T wave abnormalities (RR=2.76, p<O.OO1), and left ventricular hypertrophy (RR=4.29, p<0.01). ST segment and T wave changes and left ventricular hypertrophy each remained significant prognostic factors even after adjusting for post-MI electrocardiographic classification. An abnormal follow-up electrocardiographic examination was no longer prognostic once ST segment or T wave abnormalities or atrioventricular block on the electrocardiographic tracing before MI were considered. When simultaneous adjustment is made for each of the preexisting electrocardiographic abnormalities (ST segment and T wave abnormalities, left ventricular hypertrophy, and atrioventricular block), the risk conferred by an abnormal follow-up ECG (RR=1.22-1.82, depending on category) is no longer statistically significant. An abnormal follow-up ECG, however, particularly in the absence of a Q wave MI (RR=3.6, p<0.01), retained predictive value after adjustment The Q wave MI is documented by a panel of Framingham physicians from the ECG obtained at the time of hospitalization. Its persistence or disappearance was based on the findings of the follow-up ECG performed at a subsequent biennial examination. We showed a Q wave MI to persist in approximately 73% of cases in whom a follow-up ECG was available. Other previous reports have demonstrated varying rates of regression of Q waves. Throughout a 1-2-year follow-up, reports have demonstrated Q waves to persist in approximately 85% of patients,16,17 although one report demonstrated complete regression of Q waves to occur in 21% of patients during 3 months.18 Others report disappearance of Q-QS abnormalities to occur in nearly half of patients in the first year, with the majority of regression occurring within 2 months. 19 In those subjects with a follow-up ECG performed at least 2 years after the infarction, partial or total regression has been demonstrated to occur in 60% of patients. 20 We demonstrated that 12.4% of persons with a Q wave MI showed a normalized ECG on follow-up. This contrasts with other reports showing that only in 5.6% of such patients do the ECGs return to normal (although reported rates of Q wave regression were similar). 21 We report that if a reference category of 4'no definite ECG abnormality" is used, an increased risk is seen in those subjects with a persistent Q wave MI, which is statistically significant when accompanied by other electrocardiographic abnormalities. This latter group comprised a full 30% of cases returning for a follow-up examination. Data from the Health Insurance Plan of New York showed the risk of death during 4.5 years to be significantly less in those persons with a history of MI or angina pectoris, whose ECG returned to normal within about 6 months, as compared with those whose ECGs did not return to normal.22 Another 5-year follow-up study demonstrated that those persons who have Q wave changes or other significant ECG changes persisting on follow-up ECG, 1-2 years after the primary infarct, have a significantly higher mortality than those with a normalized ECG.23 Furthermore, the Coronary Drug Project2 has reported Q-QS abnormalities on the follow-up ECG to be significantly associated with subsequent coronary mortality, even in multivariable analyses with other clinical and standard risk factors. Reinfarction has also been shown to be more common in those persons with progression of Q or QS wave changes during the first year after MI24 and in those with a persistent U wave at the time of hospital discharge.25 Other studies, however, have reported the persistence of diagnostic Q waves to be unrelated to subsequent survival20,26 '27 or recurrent MI.21 It is uncertain how long other specified electrocardiographic abnormalities examined in this investigation were present. By comparing the follow-up post-MI ECG with the ECG obtained before MI, we were able to demonstrate that 28% of those persons with an abnormal ECG (persistent Q wave with or without other abnormality) after MI had abnormalities other than Q waves on examination done an average of 1 year before infarction. Furthermore, of those persons with electrocardiographic abnormalities other than Q wave MI at follow-up, 41% had such abnormalities present before MI. In this study, the prognostic importance of an abnormal ECG before MI was also examined. The presence of nonspecific ST segment changes, T wave abnormalities, or left ventricular hypertrophy on the electrocardiographic tracing before infarction were grave prognostic indicators, alone, and also when considering post-MI electrocardiographic classification. In fact, ST segment and T wave abnormalities before MI were such powerful risk factors that, when adjusted for, diminished the value of the follow-up ECG. In the Coronary Drug Project,2 ST segment depression was the most important prognostic indicator after MI, and ventricular conduction defects remained significantly related to coronary death, even in multivariable analyses.
Although strong associations are apparent when predicting coronary death, this investigation failed to show a significantly increased risk of reinfarction from follow-up electrocardiographic status. It is possible that preexisting abnormalities made it more difficult to diagnose new infarctions, especially because all cases, on entry into the study, had diagnostic Q waves. This might be, in particular, the the initial Q wave MI), partially explaining the attenuated findings. Our discovery of women having a markedly different post-MI electrocardiographic profile than men, with a substantially greater proportion of women demonstrating electrocardiographic abnormalities in the absence of a persistent Q wave MI (28% vs. 11% in men), to our knowledge, has not been demonstrated elsewhere. These abnormalities other than Q wave MI, if more common in women than in men, can contribute to their greater early mortality after MI, as demonstrated by other investigators.2829 In relation to location of initial MI, our discovery that those persons with an anterior MI were less likely to have a normalized ECG after MI might help explain reports in the literature demonstrating that such individuals have a poorer prognosis. [30] [31] [32] It is clear that other clinical variables and standard risk factors have an important role in post-MI risk stratification. Some investigators have questioned whether the follow-up ECG yields additional prognostic usefulness if other clinical information such as persistent heart failure or heart enlargement on x-ray are available. 33 We demonstrated the continuing grave prognosis of an abnormal ECG without a persistent Q wave MI even after noting other relevant clinical and standard risk factors. Although systolic blood pressure was strongly associated with post-MI electrocardiographic status (apparently because of its strong relation to left ventricular hypertrophy), both remained independent predictors of coronary heart disease death in multivariable analyses.
The fact that individuals must survive 1 year, on average, to attend the follow-up exam precludes the ability to detect the prognostic importance of those electrocardiographic abnormalities that are associated with the greatest early mortality. A larger study has demonstrated the presence of bundle branch block and premature ventricular beats are important predictors of 5-year all-cause and cardiovascular mortality.2 In our investigation, however, the ability to detect the separate impact of these factors was limited because of the few survivors presenting with these abnormalities on their follow-up ECG. Only for nonspecific ST segment and T wave abnormalities were the age-and sex-adjusted RRs statistically significant for predicting coronary death. The findings of this study are, therefore, most applicable to relatively healthy cohorts of survivors of MI (e.g., those who have survived an average of 1 year).
Our data underscore the prognostic importance of the follow-up ECG, after an initial infarction, as a means for risk stratification, independent of the effects conferred by the standard risk factors. This is important, considering that prognosis is poorer for those with high blood cholesterol, hypertension, and diabetes.2,14,15,22 The follow-up ECG after MI, in which the Q wave has disappeared but with other abnormalities present, is demonstrated in this report to be a grave prognostic indicator. This influence remains strong even after the effect on prognosis of an abnormal ECG or left ventricular hypertrophy detected before infarction is considered, although certain abnormalities existing before MI, such as ST segment and T wave abnormalities are strongly associated with post-MI prognosis and, when taken into consideration, attenuate markedly the predictive value of the follow-up ECG. Nevertheless, our data emphasize the continuing importance of the routine follow-up ECG, years after recovery from MI. Additional information on electrocardiographic abnormalities present before infarction can also be useful in helping to predict long-term prognosis. Abnormalities detected on the follow-up ECG, even if not accompanied by symptoms, may warrant more aggressive diagnostic or therapeutic measures.
